Calendar Tarsus Pharmaceuticals, Inc.

Equities

TARS

US87650L1035

Market Closed - Nasdaq 04:00:00 2024-04-12 pm EDT 5-day change 1st Jan Change
36.17 USD -5.54% Intraday chart for Tarsus Pharmaceuticals, Inc. +4.12% +78.62%

Chart calendar Tarsus Pharmaceuticals, Inc.

15f.wprKsnktmxEjsSefz8wESAQ1EWY7r2REt39hc2yU890.m8qw3zxK7FNR0k2y4rlWCXBsdhIPnBcm-A8iRS3aprav3_PeMnfOZ0_TYg~53960c859e368bc072ee0323c15870ac

Upcoming events on Tarsus Pharmaceuticals, Inc.

2024-05-06 Q1 2024 Earnings Release (Projected)
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-03-16 Q4 2024 Earnings Release (Projected)

Past events on Tarsus Pharmaceuticals, Inc.

2024-03-13 09:30 am Guggenheim Healthy Altitudes Summit - Fireside Chat
2024-03-12 Jefferies Biotech on the Bay Summit
2024-03-12 03:05 pm Barclays Global Healthcare Conference - Fireside Chat
2024-02-27 08:00 am Q4 2023 Earnings Call
2024-02-27 06:00 am Q4 2023 Earnings Release
2024-02-08 01:00 pm Guggenheim Healthcare Talks Biotechnology Conference
2023-11-09 04:30 pm Q3 2023 Earnings Call
2023-11-09 04:05 pm Q3 2023 Earnings Release
2023-09-12 12:30 pm Morgan Stanley Global Healthcare Conference
2023-09-11 12:30 pm H.C. Wainwright Global Investment Conference
2023-08-10 04:05 pm Q2 2023 Earnings Release
2023-07-25 08:30 am XDEMVY™ Phase 2a Trial Results Call
2023-06-22 12:00 pm Annual General Meeting
2023-06-15 11:30 am Business Update Call
2023-06-07 02:30 pm Jefferies Global Healthcare Conference - Fireside Chat
2023-05-09 Bank of America Healthcare Conference
2023-05-09 04:05 pm Q1 2023 Earnings Release
2023-03-15 04:05 pm Barclays Global Healthcare Conference
2023-03-15 10:30 am Guggenheim Health Altitudes Summit
2023-03-13 04:05 pm Q4 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
57,0
49,1
16.22%
25,8
25,9
-0.17%
17,4
9,70
79.91%

98,9

EBITDA
Million USD
Released
Forecast
Spread
-26,9
-28,5
5.55%
-11,8
-15,4
23.32%
-62,4
-62,5
0.21%
-142
-138
-3.02%

-132

EBIT
Million USD
Released
Forecast
Spread
-27,0
-28,3
4.68%
-12,2
-13,6
10.54%
-62,7
-57,0
-9.93%
-143
-144
0.6%

-154

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-26,8
-27,9
4.04%
-13,8
-14,6
5.78%
-62,1
-55,1
-12.75%
-136
-137
0.83%

-149

Net income
Million USD
Released
Forecast
Spread
-26,8
-28,1
4.53%
-13,8
-14,9
7.06%
-62,1
-57,9
-7.22%
-136
-137
0.96%

-149

EPS
USD
Released
Forecast
Spread
-4,32
-2,27
-90.14%
-0,67
-0,57
-16.96%
-2,52
-2,36
-6.78%
-4,62
-4,79
3.52%

-4,43

Announcement Date31/03/2114/03/2213/03/2327/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
0,34
4,87
-93.05%
0,54
2,20
-75.5%
15,3
11,3
35.8%
0,00
3,50
-
10,0
10,0
0%
2,50
3,33
-25%
0,00
0,00
-
1,87
0,36
418.28%
13,1
5,92
120.73%

17,4


22,8


26,3


32,8




EBITDA
Million USD
Released
Forecast
Spread
-14,4
-17,0
15.25%
-19,5
-23,0
15.3%
-5,13
-25,4
79.8%
-22,8
-23,4
2.51%
-15,0
-16,0
6.48%
-24,8
-22,0
-12.95%
-32,6





-44,1
-36,1
-22.13%















EBIT
Million USD
Released
Forecast
Spread
-14,4
-15,5
6.8%
-19,5
-22,0
11.46%
-5,22
-18,3
71.51%
-22,9
-25,8
11.38%
-15,1
-18,1
16.96%
-25,0
-23,6
-5.56%
-32,8
-29,4
-11.46%
-40,9
-41,9
2.38%
-44,5
-44,9
1.11%

-41,4


-39,6


-37,7


-34,8




Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-14,8
-15,8
6.08%
-20,2
-24,5
17.55%
-5,74
-21,5
73.25%
-22,5
-28,1
19.9%
-13,6
-18,3
25.51%
-23,4
-22,9
-2.14%
-31,4
-29,1
-7.9%
-39,1
-41,9
6.62%
-41,9
-45,4
7.74%

-42,3


-39,8


-39,9


-37,9




Net income
Million USD
Released
Forecast
Spread
-14,9
-15,4
3.8%
-20,2
-22,2
8.8%
-5,74
-18,5
68.88%
-22,5
-26,0
13.33%
-13,6
-18,1
25.05%
-23,4
-23,5
0.5%
-31,4
-28,6
-9.9%
-39,1
-41,1
4.66%
-41,9
-43,7
4.08%

-39,6


-38,7


-37,4


-34,5




EPS
USD
Released
Forecast
Spread
-0,72
-0,75
3.57%
-0,98
-0,92
-6.72%
-0,24
-0,72
66.57%
-0,84
-0,97
13.7%
-0,49
-0,69
28.99%
-0,88
-0,95
6.88%
-1,17
-1,08
-8.5%
-1,28
-1,39
7.78%
-1,31
-1,32
0.76%

-1,22


-1,14


-1,09


-0,99


-1,36

Announcement Date14/03/2210/05/2211/08/2209/11/2213/03/2309/05/2310/08/2309/11/2327/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. TARS Stock
  4. Calendar Tarsus Pharmaceuticals, Inc.